What is the appropriate management for a 3-year-old child with protracted bacterial bronchitis?

Management of Protracted Bacterial Bronchitis in a 3-Year-Old

Initiate a 2-week course of amoxicillin-clavulanate (25-35 mg/kg twice daily) targeting common respiratory bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), and if the wet cough resolves, the diagnosis of PBB is confirmed. 1

Initial Assessment and Treatment

Before starting antibiotics, ensure the child has:

• Chronic wet cough lasting >4 weeks 1
• No specific cough pointers such as:
  • Coughing with feeding (suggests aspiration)
  • Digital clubbing (suggests underlying chronic lung disease)
  • Failure to thrive
  • Dysphagia 1

If these warning signs are present, proceed directly to investigations (flexible bronchoscopy, chest CT, immunologic evaluation) rather than empiric antibiotics. 1

Antibiotic Selection and Duration

First-line therapy:

• Amoxicillin-clavulanate is the preferred antibiotic (Grade 1A recommendation) 1
• Dose: 25-35 mg/kg twice daily orally 2
• Initial duration: 2 weeks 1

The 2-week duration is supported by high-quality evidence showing clinical cure rates of approximately 70% by day 28. 2 While a 2021 randomized controlled trial found that 4-week courses did not significantly improve cure rates compared to 2-week courses (62% vs 70%, p=0.49), the longer duration did result in significantly longer time to next exacerbation (median 150 vs 36 days). 2

Management Algorithm Based on Response

If cough resolves within 2 weeks:

• Diagnosis of PBB is confirmed 1
• No further investigations needed
• Monitor for recurrence

If wet cough persists after 2 weeks:

• Extend antibiotics for an additional 2 weeks (total 4 weeks) 1
• This is a Grade 1C recommendation 1
• Consider that some children require longer courses for complete resolution 3

If wet cough persists after 4 weeks of appropriate antibiotics:

• Undertake further investigations (Grade 2B recommendation) 1
• Flexible bronchoscopy with quantitative cultures and sensitivities 1
• Consider chest CT scan 1
• Evaluate for underlying diseases:
  • Bronchiectasis 4, 5
  • Immunodeficiency 1
  • Chronic aspiration 1
  • Airway malacia 4

Important Clinical Considerations

Common pitfalls to avoid:

• Do not misdiagnose as asthma - This is the most common pre-referral misdiagnosis, occurring in approximately 15-34% of PBB cases 6
• Do not use inappropriate antibiotics - Third-generation cephalosporins and macrolides are commonly misprescribed but are not first-line 7
• Do not use corticosteroids - These are not indicated for PBB 8

Recurrent PBB (>3 episodes per year):

• Represents a significant risk factor for future bronchiectasis 4, 3
• Consider chest CT and bronchoscopy to evaluate for early bronchiectasis 4
• Longer initial antibiotic courses (6 weeks) may reduce recurrence risk compared to 2-week courses 3
• Close follow-up is essential 4

Microbiological Considerations

The most common pathogens in PBB are:

• Haemophilus influenzae (most common) 4, 9
• Streptococcus pneumoniae 1, 4, 9
• Moraxella catarrhalis 1, 4, 9

If bronchoscopy is performed and bronchoalveolar lavage shows ≥10⁴ cfu/mL of respiratory bacteria, use the term "microbiologically-based-PBB" (PBB-micro) to differentiate from clinically-based PBB. 1

Quality of Life Impact

Treatment significantly improves parent-proxy cough-specific quality of life scores from baseline to day 28, regardless of whether 2-week or 4-week courses are used. 2 Early recognition and appropriate treatment are crucial to prevent progression to chronic suppurative lung disease or bronchiectasis, which carry substantial morbidity. 4, 5, 8